Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effectiveness of Hydroxychloroquine Versus Methotrexate in the Treatment of Frontal Fibrosing Alopecia in Routine Clinical Care: a Patient Preference Trial

NCT07190534 is registered in ClinicalTrials.gov with Erasmus Medical Center as lead sponsor.

NCT NCT07190534
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07190534 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effectiveness of Hydroxychloroquine Versus Methotrexate in the Treatment of Frontal Fibrosing Alopecia in Routine Clinical Care: a Patient Preference Trial
Lead sponsor
Erasmus Medical Center
Phase
Observational
Overall status
Not yet recruiting
Start date
November 30, 2025
Completion date
May 31, 2027
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cicatricial alopecia, frontal fibrosing alopecia